ALKS
Alkermes plc
NASDAQ · Healthcare · Biotechnology · IE
$46.10
−1.66%Leverage
- Debt / equity
- 0.87x
- Net debt / equity
- 0.59x
- Debt / assets
- 0.36x
- Debt / EBITDA
- 7.21x
- Net debt / EBITDA
- 4.87x
Liquidity & coverage
- Current ratio
- 2.30x
- Quick ratio
- 1.85x
- Cash ratio
- 0.99x
- Interest coverage
- 1.98x
- EBITDA / interest
- 3.69x
- Working capital
- $860.8M
Cash & dividend
- FCF / debt
- 0.14x
- Cash flow / debt
- 0.16x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026